ANTHEM Q4 FY26 Guidance vs Delivery (ANTHEM Management Mirror)

Did ANTHEM's management deliver what it guided? Guidance vs actual performance and tone changes across recent earnings calls, as of the Q4 FY26 (Mar-2026 Qtr) concall.

  • ANTHEM Financials
  • ANTHEM Shareholding Pattern
  • ANTHEM Earnings Documents
  • ANTHEM Announcements
  • ANTHEM Corporate Actions
  • ANTHEM Bulk, Block & Insider Deals
  • ANTHEM Delivery Data
  • ANTHEM Earnings Concalls
  • Market Timeline
  • Concall Monitor
  • Company Research
  • Earnings Monitor
  • Upcoming Results
  • Sector Monitor
  • Sector Performance
  • Bulk & Block Deals
  • Delivery Data
  • FII & DII Activity
  • Market Indices
  • Plans & Pricing

Anthem Biosciences Ltd (ANTHEM) Q4FY26 Management Mirror - Mar-2026 Qtr

Revenue Growth

Management returned to its aspiration for ~20% long-term revenue growth in the Mar’26 Qtr, recovering from a moderated mid-teens (15%-16%) guidance provided in the Dec'25 Qtr, which had dipped from the original ~20% long-term CAGR target cited in the Sep'25 Qtr. [Status: Upgraded]

5 more themes on the ELITE plan.

  • ANTHEM Q4FY26 Concall Summary
  • ANTHEM Q4FY26 Concall Transcript
  • ANTHEM Q3FY26 Management Mirror (Dec-2025 Qtr)
  • ANTHEM Q1FY27 Management Mirror (Jun-2026 Qtr)